J&J To Pay $48M To Man Hurt By Motrin
A Los Angeles jury has ordered Johnson & Johnson and its McNeil Consumer Healthcare unit to pay $48.2 million to a man who developed a severe skin disorder and blood blisters in his mouth after taking the Motrin over-the-counter pain reliever. In reaching its decision, the jury found that the Motrin labeling was inadequate and […]
Read More »Category : News
Tax Holidays, Job Losses And Pharma
As talk on Capitol Hill turns toward a possible ‘tax holiday’ for large corporations with huge sums of money parked overseas, a new report points out that many of the companies that benefit from that congressional largesse may have gained a big subsidy, but also eliminated thousands of jobs. And high on that list are […]
Read More »Category : News
Bayer puts sharper focus on Japan
Bayer says that it will expand its business in Japan, “despite the difficult conditions following the earthquake and tsunami disaster” and expects solid sales growth in the coming years. Chairman Marijn Dekkers, speaking at a news conference held in Tokyo to mark the centenary of Bayer’s Japanese subsidiary, said the country “has been and continues […]
Read More »Category : News
Why Contract Research Organizations Are Hot
With more drugmakers outsourcing more trials to contract research organizations, few should be surprised that the CRO sector is generating investor interest. The attention-grabbing deal announced yesterday in which two private equity firms – Carlyle Group and Hellman & Friedman – agreed to pay $3.9 billion in cash to buy Pharmaceutical Product Development is no […]
Read More »Category : News
J&J Wins Shareholder Suit Over Board Misconduct
A federal court judge has tossed a so-called derivate lawsuit in which a group of Johnson & Johnson shareholders charged that the health care giant’s board of directors breached their fiduciary duty, despite a series of red flags in the form of FDA warning letters; government subpoenas; a criminal plea to kickback charges; whistleblower lawsuits; […]
Read More »Category : News
FDA agrees to deal that speeds reviews
The Food and Drug Administration and the biopharma industry have agreed in principle on a revamp of the Prescription Drug User Fee Act, by which drug firms provide nearly two-thirds of what the agency spends on drug reviews. The agency, which is still wrangling with the generic drug and device industries over user fee agreements, […]
Read More »Category : News
Cephalon Gets U.S. Justice Department Subpoena for Top-Sellers
Cephalon Inc. (CEPH) received a subpoena from the U.S. Justice Department asking for information about the marketing of Nuvigil and Provigil, the company’s best- selling medicines to promote wakefulness. Cephalon, based in Frazer, Pennsylvania, said it will fully cooperate and is responding to the request, which was disclosed in a filing with the U.S. Securities […]
Read More »Category : News
A Grieving J&J Employee And Cubicle Photos
NEW WEBINAR – What You’ve Got to Know About the Incoming Bombshell – FDA’s 2011 Process Validation Guidance In 2003, Cecelia Mavica Ingraham, an administrative assistant in a marketing department at Johnson & Johnsons’ Ortho-McNeil Pharmaceutical unit, learned that her teenaged daughter had acute lymphocytic leukemia. By May 2005, her daughter had passed away, but […]
Read More »Category : News
Merck Wins A Bellwether Fosamax Trial
NEW WEBINAR – What You’ve Got to Know About the Incoming Bombshell – FDA’s 2011 Process Validation Guidance A federal court jury this morning decided that the Fosamax osteoporosis drug should not be blamed for causing a type of jaw damage known as osteonecrosis in which tissue is severely damaged. Linda Secrest had filed a […]
Read More »Category : News
FDA Still Trying To Become More Transparent
As part of an ongoing ‘transparency initiative‘ launched by FDA commish Margaret Hamburg, several agency officials met with their counterparts at the US Environmental Protection Agency and the US Department of Labor to find additional ways to organize and present information that so many people have difficulty finding on the FDA website. NEW WEBINAR – […]
Read More »Category : News
